KELLBENX INC has a total of 18 patent applications. Its first patent ever was published in 2005. It filed its patents most often in United States, EPO (European Patent Office) and Australia. Its main competitors in its focus markets biotechnology, measurement and machines are IRIS MOLECULAR DIAGNOSTICS INC, NANOTYPE GMBH and SHANDONG TECHNICAL CT INSPECTION & QUARANTINE.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 7 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Australia | 2 | |
#4 | China | 2 | |
#5 | WIPO (World Intellectual Property Organization) | 2 | |
#6 | Brazil | 1 | |
#7 | Canada | 1 |
# | Industry | |
---|---|---|
#1 | Biotechnology | |
#2 | Measurement | |
#3 | Machines |
# | Technology | |
---|---|---|
#1 | Analysing materials | |
#2 | Measuring microorganism processes | |
#3 | Microorganisms | |
#4 | Peptides | |
#5 | Unspecified technologies |
# | Name | Total Patents |
---|---|---|
#1 | Kellner Leonard H | 13 |
#2 | Bennani Hassan | 13 |
#3 | Khosravi Javad | 7 |
#4 | Stachelhaus Stefan | 3 |
#5 | Albert Winfried | 3 |
#6 | Zimmermann Silke | 3 |
#7 | Hollmann Christiane | 3 |
#8 | Leonard H Kellner | 1 |
#9 | Christiane Hollmann | 1 |
#10 | Stefan Stachelhaus | 1 |
Publication | Filing date | Title |
---|---|---|
US2016130553A1 | PREPARATION OF FETAL NUCLEATED RED BLOOD CELLS (NRBCs) FOR DIAGNOSTIC TESTING | |
CN106488981A | The preparation of the fetal nucleated red blood (NRBCS) for diagnostic test | |
CN104364389A | Detection, isolation and analysis of rare cells in biological fluids | |
US2014315748A1 | Detection, isolation and analysis of rare cells in biological fluids | |
BR112014011660A2 | methods for isolating or enriching, detecting and estimating the number of rare cells per unit of biological mammalian fluid and kit for capturing, detecting or isolating them |